Physiological changes in human cardiac sympathetic innervation and activity assessed by123I-metaiodobenzylguanidine (MIBG) imaging

Circulation Journal

Volumn 73, Issue 2, 2009, Pages 310-315

  Sakata, Kazuyuki ^a,b   Iida, Kei ^a   Mochizuki, Nao ^a   Ito, Michitoshi ^b   Nakaya, Yoshihiro ^b  

^a Divisions of Cardiology   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Aging; Nuclear medicine; Sex; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADRENERGIC SYSTEM; ADULT; AGED; AGING; ANGIOCARDIOGRAPHY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; HEART CONTRACTION; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MENOPAUSE; SEX DIFFERENCE; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; HEART; HEART CATHETERIZATION; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; RADIOPHARMACEUTICALS; SEX CHARACTERISTICS; SYMPATHETIC NERVOUS SYSTEM;

EID: 59449103943     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0614     Document Type: Article

References (32)

1. Remme WJ. The sympathetic nervous system and ischaemic heart disease. Eur Heart J 1998; 19: F62 - F71.
2. Kaye D, Esler M. Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc Res 2005; 66: 256 - 264.
3. Anderson KP. Sympathetic nervous system activity and ventricular tachyarrhythmias: Recent advances. Ann Noninvasive Electrocardiol 2003; 8: 75 - 89.
4. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85(Suppl): I-77 - I-91.
5. Lerner DJ, Kannel WB. Pattern of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986; 111: 383 - 390.
6. Stokes J 3rd, Kannel WB, Wolf PA, Cupples LA, D' Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among women and men from 35-64 years: 30 years of follow-up in the Framingham Study. Circulation 1987; 75: V-65 - V-73.
7. Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature 1976; 261: 333 - 335.
8. Kuo TB, Lin T, Yang CC, Li CL, Chen CF, Chou P. Effect of aging on gender differences in neural control of heart rate. Am J Physiol 1999; 277: H2233 - H2239.
9. Ramaekers D, Ector H, Aubert AE, Rubens A, Van de Werf F. Heart rate variability and heart rate in healthy volunteers: Is the female autonomic nervous system cardioprotective? Eur Heart J 1998; 19:1334 - 1341.
10. Esler MD, Thompson JM, Kaye DM, Turner AG, Jennings GL, Cox HS, et al. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 1995; 91: 351 - 358.
11. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993; 21: 498 - 503.
12. Matsukawa T, Sugiyama Y, Watanabe T, Kobayashi F, Mano T. Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol 1998; 275: R1600 - R1604.
13. Narkiewicz K, Philips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005; 45: 522-525.
14. Sakata K, Shirotani M, Yoshida H, Kurata C. Physiological fluctuation of the human left ventricle sympathetic nervous system assessed by Idine-123-MIBG. J Nucl Med 1998; 39: 1667 - 1671.
15. Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995; 36: 969 - 974.
16. Estorch M, Carrio I, Berna L, Lopez-Pousa J, Torres G. Myocardail iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol 1995; 2: 126 - 132
17. Sakata K, Shirotani M, Yoshida H, Kurata C. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential cardiology. J Am Coll Cardiol 1998; 32: 438 - 443.
18. Yamazaki J, Muto H, Kabano T, Yamashita S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomy- opathy: Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001; 141: 645 - 652 .
19. Tsutamoto T, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, et al. Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure. Circ J 2008; 72: 740 - 746.
20. Arimoto T, Sukekawa H, Harada M, Takayama S, Ikeno E, Nishigi K, et al. Short cardiac iodine-123-metaiodobenzylguanidine imaging protocol in heart failure. Circ J 2008; 72: 1106 - 1111.
21. Austin WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 7 - 38.
22. Gao DW, Talke PO, Dae MW. Effects of reduced sympathetic activity on myocardial metaiodobenzylguanidine (MIBG) washout. J Auton Pharmacol 2001; 21: 159 - 164.
23. Akamatsu FE, De-Souza RR, Liberti EA. Fall in the number of intra- cardiac neurons in aging rats. Mech Ageing Dev 1999; 109: 153 - 161.
24. Goldberg PB, Kreider MS, McLean MR, Roberts J. Effects of aging at the adrenergic cardiac neuroeffector junction. Fed Proc 1986; 45:45 - 47.
25. Poller U, Nedelka G, Radke J, Ponicke K, Brodde OE. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 1997; 29: 187 - 193.
26. Du XJ, Dart AM, Riemersma RA. Sex differences in the parasympa- thetic nerve control of rat heart. Clin Exp Pharmacol Physiol 1994; 21: 485 - 493.
27. Li ST, Holmes C, Kopin IJ, Goldstein DS. Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluorodopamine PET scanning. J Nucl Med 2003; 44: 1599 - 1603.
28. Vongpatanasin WV, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001; 103: 2903 -2908.
29. Liu CC, Kuo TB, Yang CC. Effects of estrogen on gender-related autonomic differences in humans. Am J Physiol Heart Circ Physiol 2003; 285: H2188 - H2193.
30. Lobo RA. Surgical menopause and cardiovascular risks. Menopause 2007; 14: 562 - 566.
31. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321 - 333.
32. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part I: Aging arteries: A "Set up" for vascular disease. Circulation 2003; 107: 139 - 146.